nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—prostate cancer	0.49	1	CbGaD
Trisalicylate-choline—PTGS2—Etoposide—prostate cancer	0.0522	0.542	CbGbCtD
Trisalicylate-choline—PTGS1—Etoposide—prostate cancer	0.0441	0.458	CbGbCtD
Trisalicylate-choline—Magnesium salicylate—PTGS2—prostate cancer	0.000481	0.54	CrCbGaD
Trisalicylate-choline—Salsalate—PTGS2—prostate cancer	0.000409	0.459	CrCbGaD
Trisalicylate-choline—Headache—Bicalutamide—prostate cancer	0.000407	0.00158	CcSEcCtD
Trisalicylate-choline—Somnolence—Goserelin—prostate cancer	0.000402	0.00156	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Doxorubicin—prostate cancer	0.000401	0.00156	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Mitoxantrone—prostate cancer	0.0004	0.00155	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Epirubicin—prostate cancer	0.000398	0.00155	CcSEcCtD
Trisalicylate-choline—Somnolence—Conjugated Estrogens—prostate cancer	0.000398	0.00154	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Goserelin—prostate cancer	0.000398	0.00154	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Epirubicin—prostate cancer	0.000394	0.00153	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000394	0.00153	CcSEcCtD
Trisalicylate-choline—Asthma—Capecitabine—prostate cancer	0.000393	0.00153	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Goserelin—prostate cancer	0.000393	0.00153	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000389	0.00151	CcSEcCtD
Trisalicylate-choline—Pruritus—Ethinyl Estradiol—prostate cancer	0.000388	0.00151	CcSEcCtD
Trisalicylate-choline—Pain—Goserelin—prostate cancer	0.000386	0.0015	CcSEcCtD
Trisalicylate-choline—Constipation—Goserelin—prostate cancer	0.000386	0.0015	CcSEcCtD
Trisalicylate-choline—Nausea—Bicalutamide—prostate cancer	0.000386	0.0015	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Doxorubicin—prostate cancer	0.000385	0.0015	CcSEcCtD
Trisalicylate-choline—Pain—Conjugated Estrogens—prostate cancer	0.000383	0.00149	CcSEcCtD
Trisalicylate-choline—Constipation—Conjugated Estrogens—prostate cancer	0.000383	0.00149	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Capecitabine—prostate cancer	0.000376	0.00146	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000376	0.00146	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Goserelin—prostate cancer	0.000372	0.00145	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Etoposide—prostate cancer	0.000369	0.00143	CcSEcCtD
Trisalicylate-choline—Weight increased—Docetaxel—prostate cancer	0.000369	0.00143	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Doxorubicin—prostate cancer	0.000369	0.00143	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Doxorubicin—prostate cancer	0.000365	0.00142	CcSEcCtD
Trisalicylate-choline—Dizziness—Ethinyl Estradiol—prostate cancer	0.000363	0.00141	CcSEcCtD
Trisalicylate-choline—Flushing—Etoposide—prostate cancer	0.000363	0.00141	CcSEcCtD
Trisalicylate-choline—Confusional state—Estradiol—prostate cancer	0.000361	0.0014	CcSEcCtD
Trisalicylate-choline—Urticaria—Goserelin—prostate cancer	0.000359	0.00139	CcSEcCtD
Trisalicylate-choline—Oedema—Estradiol—prostate cancer	0.000358	0.00139	CcSEcCtD
Trisalicylate-choline—Weight increased—Capecitabine—prostate cancer	0.000357	0.00139	CcSEcCtD
Trisalicylate-choline—Urticaria—Conjugated Estrogens—prostate cancer	0.000355	0.00138	CcSEcCtD
Trisalicylate-choline—Shock—Estradiol—prostate cancer	0.000352	0.00137	CcSEcCtD
Trisalicylate-choline—Vomiting—Ethinyl Estradiol—prostate cancer	0.000349	0.00136	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Estradiol—prostate cancer	0.000346	0.00134	CcSEcCtD
Trisalicylate-choline—Rash—Ethinyl Estradiol—prostate cancer	0.000346	0.00134	CcSEcCtD
Trisalicylate-choline—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000346	0.00134	CcSEcCtD
Trisalicylate-choline—Headache—Ethinyl Estradiol—prostate cancer	0.000344	0.00134	CcSEcCtD
Trisalicylate-choline—Epistaxis—Docetaxel—prostate cancer	0.000341	0.00132	CcSEcCtD
Trisalicylate-choline—Confusional state—Mitoxantrone—prostate cancer	0.000336	0.00131	CcSEcCtD
Trisalicylate-choline—Oedema—Mitoxantrone—prostate cancer	0.000334	0.0013	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Etoposide—prostate cancer	0.000333	0.00129	CcSEcCtD
Trisalicylate-choline—Epistaxis—Capecitabine—prostate cancer	0.00033	0.00128	CcSEcCtD
Trisalicylate-choline—Shock—Mitoxantrone—prostate cancer	0.000328	0.00127	CcSEcCtD
Trisalicylate-choline—Nausea—Ethinyl Estradiol—prostate cancer	0.000326	0.00127	CcSEcCtD
Trisalicylate-choline—Hepatitis—Docetaxel—prostate cancer	0.000325	0.00126	CcSEcCtD
Trisalicylate-choline—Lethargy—Epirubicin—prostate cancer	0.000323	0.00125	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000323	0.00125	CcSEcCtD
Trisalicylate-choline—Pruritus—Goserelin—prostate cancer	0.00032	0.00124	CcSEcCtD
Trisalicylate-choline—Somnolence—Estradiol—prostate cancer	0.000318	0.00124	CcSEcCtD
Trisalicylate-choline—Weight increased—Prednisone—prostate cancer	0.000318	0.00124	CcSEcCtD
Trisalicylate-choline—Anorexia—Mitoxantrone—prostate cancer	0.000318	0.00124	CcSEcCtD
Trisalicylate-choline—Pruritus—Conjugated Estrogens—prostate cancer	0.000317	0.00123	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Estradiol—prostate cancer	0.000315	0.00122	CcSEcCtD
Trisalicylate-choline—Hepatitis—Capecitabine—prostate cancer	0.000314	0.00122	CcSEcCtD
Trisalicylate-choline—Hypotension—Mitoxantrone—prostate cancer	0.000312	0.00121	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Estradiol—prostate cancer	0.000311	0.00121	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Goserelin—prostate cancer	0.000309	0.0012	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Docetaxel—prostate cancer	0.000307	0.00119	CcSEcCtD
Trisalicylate-choline—Pain—Estradiol—prostate cancer	0.000306	0.00119	CcSEcCtD
Trisalicylate-choline—Constipation—Estradiol—prostate cancer	0.000306	0.00119	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000306	0.00119	CcSEcCtD
Trisalicylate-choline—Flushing—Docetaxel—prostate cancer	0.000301	0.00117	CcSEcCtD
Trisalicylate-choline—Lethargy—Doxorubicin—prostate cancer	0.000299	0.00116	CcSEcCtD
Trisalicylate-choline—Dizziness—Goserelin—prostate cancer	0.000299	0.00116	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Capecitabine—prostate cancer	0.000297	0.00115	CcSEcCtD
Trisalicylate-choline—Somnolence—Mitoxantrone—prostate cancer	0.000297	0.00115	CcSEcCtD
Trisalicylate-choline—Dizziness—Conjugated Estrogens—prostate cancer	0.000296	0.00115	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Estradiol—prostate cancer	0.000295	0.00115	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Mitoxantrone—prostate cancer	0.000294	0.00114	CcSEcCtD
Trisalicylate-choline—Tinnitus—Capecitabine—prostate cancer	0.000293	0.00114	CcSEcCtD
Trisalicylate-choline—Flushing—Capecitabine—prostate cancer	0.000292	0.00113	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Mitoxantrone—prostate cancer	0.00029	0.00113	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Epirubicin—prostate cancer	0.000289	0.00112	CcSEcCtD
Trisalicylate-choline—Vomiting—Goserelin—prostate cancer	0.000287	0.00112	CcSEcCtD
Trisalicylate-choline—Pain—Mitoxantrone—prostate cancer	0.000285	0.00111	CcSEcCtD
Trisalicylate-choline—Constipation—Mitoxantrone—prostate cancer	0.000285	0.00111	CcSEcCtD
Trisalicylate-choline—Rash—Goserelin—prostate cancer	0.000285	0.00111	CcSEcCtD
Trisalicylate-choline—Dermatitis—Goserelin—prostate cancer	0.000285	0.00111	CcSEcCtD
Trisalicylate-choline—Vomiting—Conjugated Estrogens—prostate cancer	0.000284	0.0011	CcSEcCtD
Trisalicylate-choline—Urticaria—Estradiol—prostate cancer	0.000284	0.0011	CcSEcCtD
Trisalicylate-choline—Headache—Goserelin—prostate cancer	0.000283	0.0011	CcSEcCtD
Trisalicylate-choline—Erythema—Docetaxel—prostate cancer	0.000283	0.0011	CcSEcCtD
Trisalicylate-choline—Rash—Conjugated Estrogens—prostate cancer	0.000282	0.0011	CcSEcCtD
Trisalicylate-choline—Dermatitis—Conjugated Estrogens—prostate cancer	0.000282	0.00109	CcSEcCtD
Trisalicylate-choline—Headache—Conjugated Estrogens—prostate cancer	0.00028	0.00109	CcSEcCtD
Trisalicylate-choline—Confusional state—Etoposide—prostate cancer	0.00028	0.00109	CcSEcCtD
Trisalicylate-choline—Hallucination—Prednisone—prostate cancer	0.000279	0.00108	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Docetaxel—prostate cancer	0.000277	0.00107	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Mitoxantrone—prostate cancer	0.000275	0.00107	CcSEcCtD
Trisalicylate-choline—Erythema—Capecitabine—prostate cancer	0.000274	0.00106	CcSEcCtD
Trisalicylate-choline—Asthma—Epirubicin—prostate cancer	0.000274	0.00106	CcSEcCtD
Trisalicylate-choline—Nausea—Goserelin—prostate cancer	0.000268	0.00104	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Etoposide—prostate cancer	0.000268	0.00104	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Capecitabine—prostate cancer	0.000268	0.00104	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Doxorubicin—prostate cancer	0.000268	0.00104	CcSEcCtD
Trisalicylate-choline—Nausea—Conjugated Estrogens—prostate cancer	0.000266	0.00103	CcSEcCtD
Trisalicylate-choline—Urticaria—Mitoxantrone—prostate cancer	0.000265	0.00103	CcSEcCtD
Trisalicylate-choline—Anorexia—Etoposide—prostate cancer	0.000265	0.00103	CcSEcCtD
Trisalicylate-choline—Flushing—Prednisone—prostate cancer	0.00026	0.00101	CcSEcCtD
Trisalicylate-choline—Hypotension—Etoposide—prostate cancer	0.000259	0.00101	CcSEcCtD
Trisalicylate-choline—Pruritus—Estradiol—prostate cancer	0.000253	0.000984	CcSEcCtD
Trisalicylate-choline—Asthma—Doxorubicin—prostate cancer	0.000253	0.000983	CcSEcCtD
Trisalicylate-choline—Weight increased—Epirubicin—prostate cancer	0.000249	0.000967	CcSEcCtD
Trisalicylate-choline—Somnolence—Etoposide—prostate cancer	0.000247	0.000958	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Estradiol—prostate cancer	0.000245	0.000952	CcSEcCtD
Trisalicylate-choline—Drowsiness—Epirubicin—prostate cancer	0.000244	0.000947	CcSEcCtD
Trisalicylate-choline—Erythema—Prednisone—prostate cancer	0.000244	0.000947	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Etoposide—prostate cancer	0.000241	0.000937	CcSEcCtD
Trisalicylate-choline—Constipation—Etoposide—prostate cancer	0.000237	0.000922	CcSEcCtD
Trisalicylate-choline—Pain—Etoposide—prostate cancer	0.000237	0.000922	CcSEcCtD
Trisalicylate-choline—Dizziness—Estradiol—prostate cancer	0.000237	0.00092	CcSEcCtD
Trisalicylate-choline—Sweating—Epirubicin—prostate cancer	0.000234	0.000908	CcSEcCtD
Trisalicylate-choline—Confusional state—Docetaxel—prostate cancer	0.000233	0.000903	CcSEcCtD
Trisalicylate-choline—Oedema—Docetaxel—prostate cancer	0.000231	0.000896	CcSEcCtD
Trisalicylate-choline—Weight increased—Doxorubicin—prostate cancer	0.00023	0.000895	CcSEcCtD
Trisalicylate-choline—Epistaxis—Epirubicin—prostate cancer	0.00023	0.000894	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Etoposide—prostate cancer	0.000229	0.000888	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Mitoxantrone—prostate cancer	0.000228	0.000887	CcSEcCtD
Trisalicylate-choline—Vomiting—Estradiol—prostate cancer	0.000228	0.000884	CcSEcCtD
Trisalicylate-choline—Shock—Docetaxel—prostate cancer	0.000227	0.000881	CcSEcCtD
Trisalicylate-choline—Rash—Estradiol—prostate cancer	0.000226	0.000877	CcSEcCtD
Trisalicylate-choline—Drowsiness—Doxorubicin—prostate cancer	0.000226	0.000877	CcSEcCtD
Trisalicylate-choline—Dermatitis—Estradiol—prostate cancer	0.000226	0.000876	CcSEcCtD
Trisalicylate-choline—Confusional state—Capecitabine—prostate cancer	0.000225	0.000875	CcSEcCtD
Trisalicylate-choline—Headache—Estradiol—prostate cancer	0.000224	0.000871	CcSEcCtD
Trisalicylate-choline—Oedema—Capecitabine—prostate cancer	0.000223	0.000867	CcSEcCtD
Trisalicylate-choline—Urticaria—Etoposide—prostate cancer	0.00022	0.000856	CcSEcCtD
Trisalicylate-choline—Anorexia—Docetaxel—prostate cancer	0.00022	0.000854	CcSEcCtD
Trisalicylate-choline—Shock—Capecitabine—prostate cancer	0.00022	0.000853	CcSEcCtD
Trisalicylate-choline—Hepatitis—Epirubicin—prostate cancer	0.000219	0.00085	CcSEcCtD
Trisalicylate-choline—Sweating—Doxorubicin—prostate cancer	0.000216	0.00084	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Capecitabine—prostate cancer	0.000216	0.000838	CcSEcCtD
Trisalicylate-choline—Hypotension—Docetaxel—prostate cancer	0.000216	0.000837	CcSEcCtD
Trisalicylate-choline—Epistaxis—Doxorubicin—prostate cancer	0.000213	0.000827	CcSEcCtD
Trisalicylate-choline—Anorexia—Capecitabine—prostate cancer	0.000213	0.000827	CcSEcCtD
Trisalicylate-choline—Nausea—Estradiol—prostate cancer	0.000213	0.000826	CcSEcCtD
Trisalicylate-choline—Vomiting—Mitoxantrone—prostate cancer	0.000212	0.000824	CcSEcCtD
Trisalicylate-choline—Rash—Mitoxantrone—prostate cancer	0.00021	0.000817	CcSEcCtD
Trisalicylate-choline—Dermatitis—Mitoxantrone—prostate cancer	0.00021	0.000816	CcSEcCtD
Trisalicylate-choline—Headache—Mitoxantrone—prostate cancer	0.000209	0.000812	CcSEcCtD
Trisalicylate-choline—Hypotension—Capecitabine—prostate cancer	0.000209	0.00081	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Epirubicin—prostate cancer	0.000207	0.000804	CcSEcCtD
Trisalicylate-choline—Somnolence—Docetaxel—prostate cancer	0.000205	0.000796	CcSEcCtD
Trisalicylate-choline—Tinnitus—Epirubicin—prostate cancer	0.000204	0.000793	CcSEcCtD
Trisalicylate-choline—Flushing—Epirubicin—prostate cancer	0.000203	0.000789	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Docetaxel—prostate cancer	0.000203	0.000789	CcSEcCtD
Trisalicylate-choline—Hepatitis—Doxorubicin—prostate cancer	0.000203	0.000787	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Docetaxel—prostate cancer	0.000201	0.000779	CcSEcCtD
Trisalicylate-choline—Oedema—Prednisone—prostate cancer	0.000199	0.000773	CcSEcCtD
Trisalicylate-choline—Nausea—Mitoxantrone—prostate cancer	0.000198	0.00077	CcSEcCtD
Trisalicylate-choline—Pain—Docetaxel—prostate cancer	0.000197	0.000766	CcSEcCtD
Trisalicylate-choline—Constipation—Docetaxel—prostate cancer	0.000197	0.000766	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Capecitabine—prostate cancer	0.000197	0.000763	CcSEcCtD
Trisalicylate-choline—Pruritus—Etoposide—prostate cancer	0.000196	0.000763	CcSEcCtD
Trisalicylate-choline—Shock—Prednisone—prostate cancer	0.000196	0.00076	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Capecitabine—prostate cancer	0.000194	0.000754	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Prednisone—prostate cancer	0.000192	0.000747	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Doxorubicin—prostate cancer	0.000192	0.000744	CcSEcCtD
Trisalicylate-choline—Constipation—Capecitabine—prostate cancer	0.000191	0.000742	CcSEcCtD
Trisalicylate-choline—Pain—Capecitabine—prostate cancer	0.000191	0.000742	CcSEcCtD
Trisalicylate-choline—Erythema—Epirubicin—prostate cancer	0.000191	0.00074	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Docetaxel—prostate cancer	0.00019	0.000738	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Etoposide—prostate cancer	0.00019	0.000738	CcSEcCtD
Trisalicylate-choline—Anorexia—Prednisone—prostate cancer	0.00019	0.000736	CcSEcCtD
Trisalicylate-choline—Tinnitus—Doxorubicin—prostate cancer	0.000189	0.000734	CcSEcCtD
Trisalicylate-choline—Flushing—Doxorubicin—prostate cancer	0.000188	0.00073	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Epirubicin—prostate cancer	0.000187	0.000725	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Capecitabine—prostate cancer	0.000184	0.000715	CcSEcCtD
Trisalicylate-choline—Dizziness—Etoposide—prostate cancer	0.000184	0.000713	CcSEcCtD
Trisalicylate-choline—Urticaria—Capecitabine—prostate cancer	0.000177	0.000689	CcSEcCtD
Trisalicylate-choline—Vomiting—Etoposide—prostate cancer	0.000176	0.000685	CcSEcCtD
Trisalicylate-choline—Erythema—Doxorubicin—prostate cancer	0.000176	0.000685	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Prednisone—prostate cancer	0.000175	0.00068	CcSEcCtD
Trisalicylate-choline—Rash—Etoposide—prostate cancer	0.000175	0.00068	CcSEcCtD
Trisalicylate-choline—Dermatitis—Etoposide—prostate cancer	0.000175	0.000679	CcSEcCtD
Trisalicylate-choline—Headache—Etoposide—prostate cancer	0.000174	0.000675	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Prednisone—prostate cancer	0.000173	0.000672	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Doxorubicin—prostate cancer	0.000173	0.000671	CcSEcCtD
Trisalicylate-choline—Constipation—Prednisone—prostate cancer	0.00017	0.000661	CcSEcCtD
Trisalicylate-choline—Nausea—Etoposide—prostate cancer	0.000165	0.00064	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Prednisone—prostate cancer	0.000164	0.000637	CcSEcCtD
Trisalicylate-choline—Pruritus—Docetaxel—prostate cancer	0.000163	0.000634	CcSEcCtD
Trisalicylate-choline—Urticaria—Prednisone—prostate cancer	0.000158	0.000614	CcSEcCtD
Trisalicylate-choline—Pruritus—Capecitabine—prostate cancer	0.000158	0.000614	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Docetaxel—prostate cancer	0.000158	0.000613	CcSEcCtD
Trisalicylate-choline—Confusional state—Epirubicin—prostate cancer	0.000157	0.000609	CcSEcCtD
Trisalicylate-choline—Oedema—Epirubicin—prostate cancer	0.000156	0.000604	CcSEcCtD
Trisalicylate-choline—Shock—Epirubicin—prostate cancer	0.000153	0.000594	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Capecitabine—prostate cancer	0.000153	0.000593	CcSEcCtD
Trisalicylate-choline—Dizziness—Docetaxel—prostate cancer	0.000153	0.000592	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Epirubicin—prostate cancer	0.00015	0.000584	CcSEcCtD
Trisalicylate-choline—Anorexia—Epirubicin—prostate cancer	0.000148	0.000576	CcSEcCtD
Trisalicylate-choline—Dizziness—Capecitabine—prostate cancer	0.000148	0.000574	CcSEcCtD
Trisalicylate-choline—Vomiting—Docetaxel—prostate cancer	0.000147	0.00057	CcSEcCtD
Trisalicylate-choline—Rash—Docetaxel—prostate cancer	0.000145	0.000565	CcSEcCtD
Trisalicylate-choline—Hypotension—Epirubicin—prostate cancer	0.000145	0.000565	CcSEcCtD
Trisalicylate-choline—Dermatitis—Docetaxel—prostate cancer	0.000145	0.000564	CcSEcCtD
Trisalicylate-choline—Confusional state—Doxorubicin—prostate cancer	0.000145	0.000564	CcSEcCtD
Trisalicylate-choline—Headache—Docetaxel—prostate cancer	0.000144	0.000561	CcSEcCtD
Trisalicylate-choline—Oedema—Doxorubicin—prostate cancer	0.000144	0.000559	CcSEcCtD
Trisalicylate-choline—Vomiting—Capecitabine—prostate cancer	0.000142	0.000551	CcSEcCtD
Trisalicylate-choline—Shock—Doxorubicin—prostate cancer	0.000142	0.00055	CcSEcCtD
Trisalicylate-choline—Rash—Capecitabine—prostate cancer	0.000141	0.000547	CcSEcCtD
Trisalicylate-choline—Pruritus—Prednisone—prostate cancer	0.000141	0.000547	CcSEcCtD
Trisalicylate-choline—Dermatitis—Capecitabine—prostate cancer	0.000141	0.000546	CcSEcCtD
Trisalicylate-choline—Headache—Capecitabine—prostate cancer	0.00014	0.000543	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Doxorubicin—prostate cancer	0.000139	0.00054	CcSEcCtD
Trisalicylate-choline—Somnolence—Epirubicin—prostate cancer	0.000138	0.000537	CcSEcCtD
Trisalicylate-choline—Anorexia—Doxorubicin—prostate cancer	0.000137	0.000533	CcSEcCtD
Trisalicylate-choline—Nausea—Docetaxel—prostate cancer	0.000137	0.000532	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Epirubicin—prostate cancer	0.000137	0.000532	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Prednisone—prostate cancer	0.000136	0.000529	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Epirubicin—prostate cancer	0.000135	0.000525	CcSEcCtD
Trisalicylate-choline—Hypotension—Doxorubicin—prostate cancer	0.000135	0.000522	CcSEcCtD
Trisalicylate-choline—Pain—Epirubicin—prostate cancer	0.000133	0.000517	CcSEcCtD
Trisalicylate-choline—Constipation—Epirubicin—prostate cancer	0.000133	0.000517	CcSEcCtD
Trisalicylate-choline—Nausea—Capecitabine—prostate cancer	0.000133	0.000515	CcSEcCtD
Trisalicylate-choline—Dizziness—Prednisone—prostate cancer	0.000132	0.000511	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Epirubicin—prostate cancer	0.000128	0.000498	CcSEcCtD
Trisalicylate-choline—Somnolence—Doxorubicin—prostate cancer	0.000128	0.000497	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Doxorubicin—prostate cancer	0.000127	0.000492	CcSEcCtD
Trisalicylate-choline—Vomiting—Prednisone—prostate cancer	0.000126	0.000491	CcSEcCtD
Trisalicylate-choline—Rash—Prednisone—prostate cancer	0.000125	0.000487	CcSEcCtD
Trisalicylate-choline—Dermatitis—Prednisone—prostate cancer	0.000125	0.000487	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Doxorubicin—prostate cancer	0.000125	0.000486	CcSEcCtD
Trisalicylate-choline—Headache—Prednisone—prostate cancer	0.000125	0.000484	CcSEcCtD
Trisalicylate-choline—Urticaria—Epirubicin—prostate cancer	0.000124	0.00048	CcSEcCtD
Trisalicylate-choline—Pain—Doxorubicin—prostate cancer	0.000123	0.000478	CcSEcCtD
Trisalicylate-choline—Constipation—Doxorubicin—prostate cancer	0.000123	0.000478	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Doxorubicin—prostate cancer	0.000119	0.000461	CcSEcCtD
Trisalicylate-choline—Nausea—Prednisone—prostate cancer	0.000118	0.000459	CcSEcCtD
Trisalicylate-choline—Urticaria—Doxorubicin—prostate cancer	0.000114	0.000444	CcSEcCtD
Trisalicylate-choline—Pruritus—Epirubicin—prostate cancer	0.00011	0.000427	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Epirubicin—prostate cancer	0.000106	0.000413	CcSEcCtD
Trisalicylate-choline—Dizziness—Epirubicin—prostate cancer	0.000103	0.0004	CcSEcCtD
Trisalicylate-choline—Pruritus—Doxorubicin—prostate cancer	0.000102	0.000396	CcSEcCtD
Trisalicylate-choline—Vomiting—Epirubicin—prostate cancer	9.89e-05	0.000384	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Doxorubicin—prostate cancer	9.85e-05	0.000383	CcSEcCtD
Trisalicylate-choline—Rash—Epirubicin—prostate cancer	9.81e-05	0.000381	CcSEcCtD
Trisalicylate-choline—Dermatitis—Epirubicin—prostate cancer	9.8e-05	0.000381	CcSEcCtD
Trisalicylate-choline—Headache—Epirubicin—prostate cancer	9.75e-05	0.000379	CcSEcCtD
Trisalicylate-choline—Dizziness—Doxorubicin—prostate cancer	9.52e-05	0.00037	CcSEcCtD
Trisalicylate-choline—Nausea—Epirubicin—prostate cancer	9.24e-05	0.000359	CcSEcCtD
Trisalicylate-choline—Vomiting—Doxorubicin—prostate cancer	9.15e-05	0.000355	CcSEcCtD
Trisalicylate-choline—Rash—Doxorubicin—prostate cancer	9.08e-05	0.000353	CcSEcCtD
Trisalicylate-choline—Dermatitis—Doxorubicin—prostate cancer	9.07e-05	0.000352	CcSEcCtD
Trisalicylate-choline—Headache—Doxorubicin—prostate cancer	9.02e-05	0.00035	CcSEcCtD
Trisalicylate-choline—Nausea—Doxorubicin—prostate cancer	8.55e-05	0.000332	CcSEcCtD
Trisalicylate-choline—PTGS2—Disease—LDHB—prostate cancer	5.93e-05	0.000382	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RPL12—prostate cancer	5.93e-05	0.000382	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—TNFRSF21—prostate cancer	5.84e-05	0.000376	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP7B1—prostate cancer	5.69e-05	0.000366	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MTAP—prostate cancer	5.69e-05	0.000366	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	5.68e-05	0.000365	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC22A3—prostate cancer	5.66e-05	0.000364	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HSD3B1—prostate cancer	5.66e-05	0.000364	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TCN2—prostate cancer	5.63e-05	0.000362	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	5.57e-05	0.000358	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	5.56e-05	0.000357	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SULT1E1—prostate cancer	5.54e-05	0.000356	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SRD5A1—prostate cancer	5.54e-05	0.000356	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	5.49e-05	0.000353	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTA4—prostate cancer	5.43e-05	0.000349	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—TBXAS1—prostate cancer	5.43e-05	0.000349	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	5.42e-05	0.000349	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	5.38e-05	0.000346	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	5.37e-05	0.000345	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	5.3e-05	0.000341	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	5.3e-05	0.000341	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTA2—prostate cancer	5.29e-05	0.00034	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HSD17B3—prostate cancer	5.29e-05	0.00034	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ACSL4—prostate cancer	5.29e-05	0.00034	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TP53—prostate cancer	5.25e-05	0.000338	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	5.24e-05	0.000337	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	5.23e-05	0.000336	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SULT1A1—prostate cancer	5.22e-05	0.000336	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ABCG5—prostate cancer	5.22e-05	0.000336	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	5.22e-05	0.000336	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTA1—prostate cancer	5.1e-05	0.000328	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ARG2—prostate cancer	5.07e-05	0.000326	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PHGDH—prostate cancer	5.07e-05	0.000326	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—UMPS—prostate cancer	5.07e-05	0.000326	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HSD3B2—prostate cancer	5.05e-05	0.000325	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTO1—prostate cancer	5.05e-05	0.000325	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NAT2—prostate cancer	5.05e-05	0.000325	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	5.04e-05	0.000324	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	4.99e-05	0.000321	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LDHB—prostate cancer	4.97e-05	0.00032	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP3A5—prostate cancer	4.88e-05	0.000314	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	4.85e-05	0.000312	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	4.85e-05	0.000312	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PLCB2—prostate cancer	4.84e-05	0.000311	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LRP2—prostate cancer	4.84e-05	0.000311	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP2C18—prostate cancer	4.84e-05	0.000311	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL6—prostate cancer	4.8e-05	0.000309	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GSTO1—prostate cancer	4.78e-05	0.000308	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—P4HB—prostate cancer	4.74e-05	0.000305	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	4.72e-05	0.000304	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PDHA1—prostate cancer	4.71e-05	0.000303	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—UCP3—prostate cancer	4.71e-05	0.000303	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTA3—prostate cancer	4.71e-05	0.000303	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—TCN2—prostate cancer	4.71e-05	0.000303	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC22A1—prostate cancer	4.62e-05	0.000297	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—LRP2—prostate cancer	4.59e-05	0.000295	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	4.56e-05	0.000293	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SULT2A1—prostate cancer	4.5e-05	0.000289	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—P4HB—prostate cancer	4.5e-05	0.000289	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—EIF2AK2—prostate cancer	4.5e-05	0.000289	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RPL10—prostate cancer	4.5e-05	0.000289	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HSD3B1—prostate cancer	4.49e-05	0.000289	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC22A3—prostate cancer	4.49e-05	0.000289	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—MED12—prostate cancer	4.42e-05	0.000285	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HIST1H2BG—prostate cancer	4.41e-05	0.000284	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GNG5—prostate cancer	4.39e-05	0.000282	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	4.36e-05	0.000281	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	4.35e-05	0.00028	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	4.34e-05	0.000279	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTA4—prostate cancer	4.31e-05	0.000277	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—TBXAS1—prostate cancer	4.31e-05	0.000277	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HIST1H4H—prostate cancer	4.26e-05	0.000274	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NPPA—prostate cancer	4.26e-05	0.000274	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	4.25e-05	0.000273	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NCOA3—prostate cancer	4.23e-05	0.000272	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	4.21e-05	0.000271	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTA2—prostate cancer	4.2e-05	0.00027	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.16e-05	0.000267	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ABCG5—prostate cancer	4.15e-05	0.000267	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SULT1A1—prostate cancer	4.15e-05	0.000267	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTA1—prostate cancer	4.05e-05	0.000261	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HPGDS—prostate cancer	4.03e-05	0.00026	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	4.02e-05	0.000258	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP2C19—prostate cancer	4.01e-05	0.000258	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HSD3B2—prostate cancer	4.01e-05	0.000258	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NAT2—prostate cancer	4.01e-05	0.000258	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTO1—prostate cancer	4.01e-05	0.000258	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTT1—prostate cancer	3.91e-05	0.000252	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ACHE—prostate cancer	3.91e-05	0.000252	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP2A6—prostate cancer	3.87e-05	0.000249	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.85e-05	0.000248	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	3.85e-05	0.000248	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PLCB2—prostate cancer	3.84e-05	0.000247	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LRP2—prostate cancer	3.84e-05	0.000247	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP2C18—prostate cancer	3.84e-05	0.000247	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—P4HB—prostate cancer	3.77e-05	0.000242	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AKR1C3—prostate cancer	3.76e-05	0.000242	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PRKACB—prostate cancer	3.74e-05	0.000241	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP17A1—prostate cancer	3.7e-05	0.000238	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	3.69e-05	0.000237	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC22A1—prostate cancer	3.66e-05	0.000236	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.65e-05	0.000235	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TGFBR1—prostate cancer	3.62e-05	0.000233	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—B2M—prostate cancer	3.62e-05	0.000233	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.62e-05	0.000233	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SULT2A1—prostate cancer	3.57e-05	0.00023	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	3.57e-05	0.00023	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RPS19—prostate cancer	3.57e-05	0.000229	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKR1C3—prostate cancer	3.57e-05	0.000229	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PRKACB—prostate cancer	3.55e-05	0.000228	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NCOA2—prostate cancer	3.53e-05	0.000227	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MED12—prostate cancer	3.51e-05	0.000226	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GNG5—prostate cancer	3.48e-05	0.000224	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PPP3CA—prostate cancer	3.46e-05	0.000222	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC5A5—prostate cancer	3.37e-05	0.000217	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NCOA3—prostate cancer	3.36e-05	0.000216	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PRKCZ—prostate cancer	3.35e-05	0.000215	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.3e-05	0.000212	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP2E1—prostate cancer	3.29e-05	0.000212	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CALR—prostate cancer	3.29e-05	0.000211	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NQO1—prostate cancer	3.25e-05	0.000209	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PARP1—prostate cancer	3.23e-05	0.000208	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FGFR4—prostate cancer	3.23e-05	0.000208	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—TH—prostate cancer	3.2e-05	0.000206	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HPGDS—prostate cancer	3.2e-05	0.000206	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CALCA—prostate cancer	3.19e-05	0.000205	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.18e-05	0.000205	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP2C19—prostate cancer	3.18e-05	0.000205	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP3A4—prostate cancer	3.17e-05	0.000204	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.15e-05	0.000203	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP1B1—prostate cancer	3.12e-05	0.000201	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTT1—prostate cancer	3.11e-05	0.0002	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ACHE—prostate cancer	3.11e-05	0.0002	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP2A6—prostate cancer	3.07e-05	0.000198	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HSPA1A—prostate cancer	3.06e-05	0.000197	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.06e-05	0.000197	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GGT1—prostate cancer	3.02e-05	0.000194	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	3.01e-05	0.000194	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AKR1C3—prostate cancer	2.99e-05	0.000192	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NCOA1—prostate cancer	2.97e-05	0.000191	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PRKACB—prostate cancer	2.97e-05	0.000191	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP17A1—prostate cancer	2.94e-05	0.000189	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CASP9—prostate cancer	2.94e-05	0.000189	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP19A1—prostate cancer	2.93e-05	0.000189	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.9e-05	0.000187	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PRKCQ—prostate cancer	2.84e-05	0.000183	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—RXRA—prostate cancer	2.83e-05	0.000182	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NCOA2—prostate cancer	2.8e-05	0.00018	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.75e-05	0.000177	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—COMT—prostate cancer	2.72e-05	0.000175	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTP1—prostate cancer	2.71e-05	0.000174	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FGF10—prostate cancer	2.7e-05	0.000174	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC5A5—prostate cancer	2.67e-05	0.000172	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ITPR1—prostate cancer	2.67e-05	0.000172	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.62e-05	0.000169	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP2E1—prostate cancer	2.61e-05	0.000168	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NQO1—prostate cancer	2.58e-05	0.000166	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TGFBR2—prostate cancer	2.57e-05	0.000165	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—TH—prostate cancer	2.54e-05	0.000164	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ITPR1—prostate cancer	2.53e-05	0.000163	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.53e-05	0.000163	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—TYMS—prostate cancer	2.52e-05	0.000162	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP3A4—prostate cancer	2.52e-05	0.000162	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTM1—prostate cancer	2.49e-05	0.00016	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP1B1—prostate cancer	2.47e-05	0.000159	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—LPL—prostate cancer	2.45e-05	0.000157	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GGT1—prostate cancer	2.4e-05	0.000154	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP1A1—prostate cancer	2.36e-05	0.000152	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NCOA1—prostate cancer	2.36e-05	0.000152	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ERCC2—prostate cancer	2.34e-05	0.000151	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP19A1—prostate cancer	2.33e-05	0.00015	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—LPL—prostate cancer	2.32e-05	0.000149	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PDGFRB—prostate cancer	2.3e-05	0.000148	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—RXRA—prostate cancer	2.25e-05	0.000144	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ERCC2—prostate cancer	2.22e-05	0.000143	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—MTHFR—prostate cancer	2.2e-05	0.000142	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.18e-05	0.000141	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ERBB3—prostate cancer	2.17e-05	0.00014	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FGFR2—prostate cancer	2.17e-05	0.00014	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—COMT—prostate cancer	2.16e-05	0.000139	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPARA—prostate cancer	2.16e-05	0.000139	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTP1—prostate cancer	2.15e-05	0.000138	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ITPR1—prostate cancer	2.12e-05	0.000136	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MTHFR—prostate cancer	2.09e-05	0.000134	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.08e-05	0.000134	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TERT—prostate cancer	2.08e-05	0.000134	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CAV1—prostate cancer	2.03e-05	0.000131	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—TYMS—prostate cancer	2e-05	0.000129	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HIF1A—prostate cancer	1.99e-05	0.000128	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTM1—prostate cancer	1.98e-05	0.000127	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—LPL—prostate cancer	1.94e-05	0.000125	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.94e-05	0.000125	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CAV1—prostate cancer	1.93e-05	0.000124	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP1A1—prostate cancer	1.88e-05	0.000121	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ERCC2—prostate cancer	1.86e-05	0.00012	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CG—prostate cancer	1.85e-05	0.000119	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—BAD—prostate cancer	1.81e-05	0.000117	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APC—prostate cancer	1.75e-05	0.000113	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—INS—prostate cancer	1.75e-05	0.000113	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MTHFR—prostate cancer	1.75e-05	0.000112	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—EGF—prostate cancer	1.73e-05	0.000112	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IRS1—prostate cancer	1.73e-05	0.000112	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CREBBP—prostate cancer	1.72e-05	0.00011	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPARA—prostate cancer	1.72e-05	0.00011	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—GSK3B—prostate cancer	1.68e-05	0.000108	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—INS—prostate cancer	1.66e-05	0.000107	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CD—prostate cancer	1.63e-05	0.000105	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CREBBP—prostate cancer	1.63e-05	0.000105	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CAV1—prostate cancer	1.61e-05	0.000104	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MAP2K1—prostate cancer	1.55e-05	9.99e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3CD—prostate cancer	1.54e-05	9.92e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.54e-05	9.91e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NOS3—prostate cancer	1.54e-05	9.88e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SERPINE1—prostate cancer	1.53e-05	9.81e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FGF2—prostate cancer	1.48e-05	9.5e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CG—prostate cancer	1.47e-05	9.45e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS3—prostate cancer	1.46e-05	9.37e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CB—prostate cancer	1.42e-05	9.12e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—JAK2—prostate cancer	1.42e-05	9.1e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTGS2—prostate cancer	1.4e-05	9.04e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—INS—prostate cancer	1.39e-05	8.95e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MDM2—prostate cancer	1.38e-05	8.89e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CREBBP—prostate cancer	1.36e-05	8.76e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ERBB2—prostate cancer	1.36e-05	8.76e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3CB—prostate cancer	1.34e-05	8.65e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CD—prostate cancer	1.29e-05	8.31e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CDKN1B—prostate cancer	1.26e-05	8.11e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTEN—prostate cancer	1.23e-05	7.88e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NOS3—prostate cancer	1.22e-05	7.84e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CTNNB1—prostate cancer	1.19e-05	7.67e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—EP300—prostate cancer	1.17e-05	7.52e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CDKN1A—prostate cancer	1.16e-05	7.49e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PTEN—prostate cancer	1.16e-05	7.47e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CB—prostate cancer	1.13e-05	7.24e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—EP300—prostate cancer	1.11e-05	7.13e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SRC—prostate cancer	1.08e-05	6.93e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—STAT3—prostate cancer	1.04e-05	6.68e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PTEN—prostate cancer	9.73e-06	6.26e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MYC—prostate cancer	9.65e-06	6.21e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—TGFB1—prostate cancer	9.63e-06	6.19e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—EGFR—prostate cancer	9.44e-06	6.07e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—EP300—prostate cancer	9.28e-06	5.97e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—KRAS—prostate cancer	8.92e-06	5.74e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CA—prostate cancer	8.64e-06	5.56e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3CA—prostate cancer	8.19e-06	5.27e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6—prostate cancer	7.26e-06	4.67e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AKT1—prostate cancer	7.06e-06	4.54e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CA—prostate cancer	6.86e-06	4.41e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKT1—prostate cancer	6.69e-06	4.31e-05	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AKT1—prostate cancer	5.61e-06	3.61e-05	CbGpPWpGaD
